---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-097730"
form_type: "8-K"
ticker: "SCLX"
cik: "0001820190"
company_name: "Scilex Holding Co"
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:23:00.878556+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "medium"
source: SEC EDGAR
---

# Scilex prelim Q1: ZTlido gross sales $34-38M (+24-38% YoY); net sales $12-13M (+13-23% YoY)

## Summary
- ZTlido gross sales Q1 2024 estimated $34-38M vs $27.5M Q1 2023, up 24-38%.
- ZTlido net sales Q1 2024 estimated $12-13M vs $10.6M Q1 2023, up 13-23%.
- Company plans to cut R&D and admin expenses in 2024; focuses on late-stage pipeline like SP-102.
- Change Healthcare co-pay processing for ZTlido restored to normal after cyber disruption.

## SEC filing metadata
- accession: 0001193125-24-097730
- form_type: 8-K
- ticker: SCLX
- cik: 0001820190
- company_name: Scilex Holding Co
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/0001193125-24-097730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/d815788d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-097730
- JSON: https://secwatch.observer/filing/0001193125-24-097730.json
- Plain text: https://secwatch.observer/filing/0001193125-24-097730.txt

## Key facts
- Earnings Releases
  Scilex Holding Co reported quarter ended March 31, 2024 results: revenue ZTlido gross sales for the first quarter of 2024 were in the range of $34.0 million to $38.0 million.
  - Period: quarter ended March 31, 2024
  - Revenue: ZTlido gross sales for the first quarter of 2024 were in the range of $34.0 million to $38.0 million
  - Result: preliminary results
  source text: Scilex Holding Company (the “Company”) is providing certain preliminary unaudited financial results for the quarter ended March 31, 2024 based on currently available information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/0001193125-24-097730-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.